Published in Biotechnol Bioeng on January 27, 2012
Intra-articular interleukin-1 receptor antagonist (IL1-ra) microspheres for posttraumatic osteoarthritis: in vitro biological activity and in vivo disease modifying effect. J Exp Orthop (2016) 0.75
An introduction to biomaterial-based strategies for curbing autoimmunity. Exp Biol Med (Maywood) (2016) 0.75
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis (2009) 6.17
Electrospinning: applications in drug delivery and tissue engineering. Biomaterials (2008) 4.12
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog (2010) 2.99
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood (2009) 2.92
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 2.55
Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis (2011) 2.35
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood (2007) 2.21
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A (2007) 2.10
Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood (2012) 2.03
Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One (2008) 1.83
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. Blood (2010) 1.72
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138. J Infect Dis (2006) 1.57
Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. J Infect Dis (2005) 1.47
TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol (2007) 1.45
Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci (2006) 1.38
Close link between CD4+ and CD8+ T cell proliferation defects in patients with human immunodeficiency virus disease and relationship to extended periods of CD4+ lymphopenia. J Infect Dis (2002) 1.19
S-phase entry leads to cell death in circulating T cells from HIV-infected persons. J Leukoc Biol (2008) 1.19
Determinants of protection among HIV‐exposed seronegative persons: an overview. J Infect Dis (2010) 1.13
HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease. J Acquir Immune Defic Syndr (2012) 1.12
Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection. AIDS (2006) 1.12
Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr (2012) 1.11
Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood (2009) 1.10
Affinity-based drug delivery. Macromol Biosci (2010) 1.06
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One (2012) 1.06
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. J Acquir Immune Defic Syndr (2015) 1.05
Antibiotic-releasing mesh coating to reduce prosthetic sepsis: an in vivo study. J Surg Res (2010) 1.02
Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection. J Virol (2008) 1.02
Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging. J Infect Dis (2009) 1.01
Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease. J Immunol (2007) 0.99
Environmental cues to guide stem cell fate decision for tissue engineering applications. Expert Opin Biol Ther (2006) 0.97
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection. Retrovirology (2008) 0.97
The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes. Immunology (2011) 0.97
Cyclodextrin-based device coatings for affinity-based release of antibiotics. Biomaterials (2009) 0.96
Cyclodextrin complexation for affinity-based antibiotic delivery. Macromol Biosci (2010) 0.93
Impaired TCR-mediated induction of Ki67 by naive CD4+ T cells is only occasionally corrected by exogenous IL-2 in HIV-1 infection. J Immunol (2003) 0.91
Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity. Pediatr Res (2011) 0.87
Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. Blood (2013) 0.86
Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. J Virol (2014) 0.86
Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection. J Acquir Immune Defic Syndr (2010) 0.86
Membrane damage and repair in primary monocytes exposed to human β-defensin-3. J Leukoc Biol (2012) 0.86
Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells. J Immunol (2011) 0.85
Supramolecular assembly of cyclodextrin-based nanoparticles on solid surfaces for gene delivery. Langmuir (2006) 0.85
Multiplexing interactions to control antibiotic release from cyclodextrin hydrogels. Macromol Biosci (2011) 0.85
Decreased IL-7 responsiveness is related to oxidative stress in HIV disease. PLoS One (2013) 0.83
Cell culture platform with mechanical conditioning and nondamaging cellular detachment. J Biomed Mater Res A (2010) 0.83
In vitro human memory CD8 T cell expansion in response to cytomegalovirus requires CD4+ T cell help. J Infect Dis (2004) 0.83
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J Clin Invest (2016) 0.83
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection. J Acquir Immune Defic Syndr (2016) 0.82
Interleukin-7 enhances proliferation responses to T-cell receptor stimulation in naïve CD4+ T cells from human immunodeficiency virus-infected persons. J Virol (2007) 0.82
In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection. Clin Immunol (2010) 0.80
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption. Curr Opin HIV AIDS (2007) 0.80
Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patients. J Leukoc Biol (2012) 0.80
Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections. J Acquir Immune Defic Syndr (2013) 0.79
Endothelial progenitor populations in differentiating embryonic stem cells I: Identification and differentiation kinetics. Tissue Eng Part A (2009) 0.79
Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery. Exp Eye Res (2013) 0.79
Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection. AIDS (2014) 0.78
Experimental studies and modeling of drug release from a tunable affinity-based drug delivery platform. Ann Biomed Eng (2011) 0.78
Frequencies of FoxP3+ naive T cells are related to both viral load and naive T cell proliferation responses in HIV disease. J Leukoc Biol (2011) 0.78
CCR5 and its ligands: a new axis of evil? Nat Immunol (2007) 0.77
Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention. Mol Pharm (2013) 0.76
A biodegradable thermoset polymer made by esterification of citric acid and glycerol. J Biomed Mater Res A (2013) 0.76
A tale of 2 biologies: stem cell patch: myocardial interactions are critical for myocardial regeneration. J Am Coll Cardiol (2011) 0.75
Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery. AIDS (2016) 0.75
Local release from affinity-based polymers increases urethral concentration of the stem cell chemokine CCL7 in rats. Biomed Mater (2016) 0.75
Cytotoxic gold(I)-bearing dendrimers from alkyne precursors. Dalton Trans (2011) 0.75
Endothelial progenitor populations in differentiating embryonic stem cells. II. Drug selection and functional characterization. Tissue Eng Part A (2010) 0.75